SEARCH

SEARCH BY CITATION

References

  • Alakhova, D.Y., Rapoport, N.Y., Batrakova, E.V., Timoshin, A.A., Li, S., Nicholls, D., Alakhov, V.Y. and Kabanov, A.V. (2010) Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release 142, 89100.
  • Ballatori, N., Li, N., Fang, F., Boyer, J.L., Christian, W.V. and Hammond, C.L. (2009) OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids. Front Biosci 14, 28292844.
  • Bals, R., Weiner, D.J., Meegalla, R.L. and Wilson, J.M. (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103, 11131117.
  • Benincasa, M., Mattiuzzo, M., Herasimenka, Y., Cescutti, P., Rizzo, R. and Gennaro, R. (2009) Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens. J Pept Sci 15, 595600.
  • Bergsson, G., Reeves, E.P., McNally, P., Chotirmall, S.H., Greene, C.M., Greally, P., Murphy, P., O’Neill, S.J. et al. (2009) LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol 183, 543551.
  • Bermpohl, D., Halle, A., Freyer, D., Dagand, E., Braun, J.S., Bechmann, I., Schröder, N.W. and Weber, J.R. (2005) Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115, 16071615.
  • Braff, M.H., Hawkins, M.A., Di Nardo, A., Lopez-Garcia, B., Howell, M.D., Wong, C., Lin, K., Streib, J.E. et al. (2005) Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174, 42714278.
  • Bucki, R., Byfield, F.J. and Janmey, P.A. (2007a) Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 29, 624632.
  • Bucki, R., Sostarecz, A.G., Byfield, F.J., Savage, P.B. and Janmey, P.A. (2007b) Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60, 535545.
  • Chen, C.I., Schaller-Bals, S., Paul, K.P., Wahn, U. and Bals, R. (2004) Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros 3, 4550.
  • Dawson, P.A., Lan, T. and Rao, A. (2009) Bile acid transporters. J Lipid Res 50, 23402357.
  • Di Sant’Agnese, P.A. (1956) Fibrocystic disease of the pancreas, a generalized disease of exocrine glands. J Am Med Assoc 160, 846853.
  • Epand, R.F., Savage, P.B. and Epand, R.M. (2007) Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins). Biochim Biophys Acta 1768, 25002509.
  • Escobar-Chávez, J.J., López-Cervantes, M., Naïk, A., Kalia, Y.N., Quintanar-Guerrero, D. and Ganem-Quintanar, A. (2006) Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Sci 9, 339358.
  • Folsom, J.P., Richards, L., Pitts, B., Roe, F., Ehrlich, G.D., Parker, A., Mazurie, A. and Stewart, P.S. (2010) Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol 10, 294.
  • Gomez, M.I. and Prince, A. (2007) Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 7, 244251.
  • Hallifax, D. and Houston, J.B. (2006) Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance. Drug Metab Dispos 34, 18291836.
  • Høiby, N., Ciofu, O. and Bjarnsholt, T. (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5, 16631674.
  • Leszczyńska, K., Namiot, A., Cruz, K., Byfield, F.J., Won, E., Mendez, G., Sokołowski, W., Savage, P.B. et al. (2011) Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections. J Appl Microbiol 110, 229238.
  • Li, C., Budge, L.P., Driscoll, C.D., Willardson, B.M., Allman, G.W. and Savage, P.B.J. (1999) Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gram-negative bacteria. J Am Chem Soc 121, 931940.
  • López-Amorós, R., Comas, J. and Vives-Rego, J. (1995) Flow cytometric assessment of Escherichia coli and Salmonella typhimurium starvation-survival in seawater using rhodamine 123, propidium iodide, and oxonol. Appl Environ Microbiol 61, 25212526.
  • Métioui, M., Grosfils, K. and Dehaye, J.P. (1994) Interaction between thapsigargin and ATP4− in the regulation of the intracellular calcium in rat submandibular glands. J Cell Physiol 161, 243248.
  • Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 5563.
  • Nagant, C., Tré-Hardy, M., El-Ouaaliti, M., Savage, P., Devleeschouwer, M. and Dehaye, J.P. (2010) Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Appl Microbiol Biotechnol 88, 251263.
  • Nagant, C., Feng, Y., Lucas, B., Braeckmans, K., Savage, P.B. and Dehaye, J.P. (2011) Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa. J Appl Microbiol 111, 763772.
  • Scaduto, R.C. Jr and Grotyohann, L.W. (1999) Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76, 469477.
  • Schmidt, E.J., Boswell, J.S., Walsh, J.P., Schellenberg, M.M., Winter, T.W., Li, C., Allman, G.W. and Savage, P.B. (2001) Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. J Antimicrob Chemother 47, 671674.
  • Seil, M., Nagant, C., Dehaye, J.P., Vandenbranden, M. and Lensink, M.F. (2010) Spotlight on human LL-37, an immunomodulatory peptide with promising cell-penetrating properties. Pharmaceuticals 3, 34353460.
  • Sievänen, E. (2007) Exploitation of bile acid transport systems in prodrug design. Molecules 12, 18591889.
  • Trainor, E.A., Horton, K.E., Savage, P.B., Testerman, T.L. and McGee, D.J. (2011) Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts. Infect Immun 79, 8897.
  • Voronina, S.G., Barrow, S.L., Gerasimenko, O.V., Petersen, O.H. and Tepikin, A.V. (2004) Effects of secretagogues and bile acids on mitochondrial membrane potential of pancreatic acinar cells: comparison of different modes of evaluating DeltaPsim. J Biol Chem 279, 2732727338.